Beyond the Stent (“Leave-Nothing-Behind”) Drug-Coated Balloons in Acute Coronary Syndrome: A Narrative Review
Journal of Clinical Medicine · 10.06.2026 · 15 (12) · 4491
DOI: 10.3390/jcm15124491 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 10.06.2026. Verfasst von Sheref Zaghloul und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Royal Berkshire Hospital, Reading RG1 5AN, UK. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Drug-coated balloons (DCBs) have emerged as a “leave-nothing-behind” strategy in percutaneous coronary intervention (PCI), with potential advantages over drug-eluting stents (DES) in selected patients with acute coronary syndrome (ACS).
Methods
We performed a narrative review of randomized controlled trials, registries, and meta-analyses evaluating DCB therapy in ACS, including PEPCAD NSTEMI, REVELATION, BASKET-SMALL 2, AGENT IDE, REC-CAGEFREE I/II, and the ongoing TRANSFORM II trial. Articles were identified through searches of PubMed/MEDLINE, Embase, Scopus, Web of Science, and Cochrane CENTRAL covering January 2005 to February 2026.
Results
Across published studies, DCBs have shown outcomes that are non-inferior to those of DES in selected ACS subsets, together with a lower risk of major bleeding attributable to shorter dual antiplatelet therapy (DAPT) requirements. Advances in intravascular imaging and lesion preparation, alongside emerging applications of artificial intelligence (AI) and robotic-assisted PCI, may further improve DCB performance, although evidence specific to DCB use in ACS remains limited for these adjunctive technologies.
Conclusions
DCBs are a reasonable alternative to DES in selected patients with ACS, particularly those at high bleeding risk or with lesion subsets in which DES perform less well (small vessels, in-stent restenosis, bifurcations, diffuse disease). Adequately powered randomized trials with long-term follow-up are required before broader recommendations can be made.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, Royal Berkshire Hospital, Reading RG1 5AN, UK.
- Cardiology Department, Hampshire Hospitals NHS Foundation Trust, Basingstoke RG24 9NA, UK.
- Cardiology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.
- Internal Medicine Department, Queen Elizabeth Hospital, Birmingham B15 2GW, UK.
- Cardiology Department, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent ST4 6QG, UK.
- Cardiology Department, Royal Free London NHS Foundation Trust, London NW3 2QG, UK.
ORCID-Profile: Ahmed Shahin, Salaheldin Agamy, Mohamed Aly, Luciano Candilio
Zitieren
APA
Zaghloul, S., Shahin, A., Agamy, S., Ioakim, K. J., Aly, M., & Candilio, L. (2026). Beyond the Stent (“Leave-Nothing-Behind”) Drug-Coated Balloons in Acute Coronary Syndrome: A Narrative Review. Journal of Clinical Medicine, 15(12), 4491. https://doi.org/10.3390/jcm15124491
Vancouver
Zaghloul S, Shahin A, Agamy S, Ioakim KJ, Aly M, Candilio L. Beyond the Stent (“Leave-Nothing-Behind”) Drug-Coated Balloons in Acute Coronary Syndrome: A Narrative Review. Journal of Clinical Medicine. 2026;15(12):4491. doi:10.3390/jcm15124491
BibTeX
@article{Zaghloul2026,
author = {Zaghloul, Sheref and Shahin, Ahmed and Agamy, Salaheldin and Ioakim, Kalliopi J and Aly, Mohamed and Candilio, Luciano},
title = {Beyond the Stent (“Leave-Nothing-Behind”) Drug-Coated Balloons in Acute Coronary Syndrome: A Narrative Review},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {12},
pages = {4491},
doi = {10.3390/jcm15124491}
}
EUVIMED